Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A biosensor for estrogenic substances using the quartz crystal microbalance.

Kendra S Carmon1, Ruth E Baltus, Linda A Luck

  • 1Department of Chemistry, Clarkson University, Potsdam, NY 13699, USA.

Analytical Biochemistry
|August 30, 2005
PubMed
Summary

This study presents a novel biosensor for detecting estrogenic substances. The engineered estrogen receptor biosensor shows sensitive and selective responses to estrogenic compounds.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LGR5: from stem cell marker to therapeutic target.

Trends in cancer·2026
Same author

Cetuximab increases LGR5 expression and augments LGR5-targeting antibody-drug conjugate efficacy in patient-derived colorectal cancer models.

Cell reports. Medicine·2025
Same author

Anti-tumor activity of camptothecin analog conjugate of an RSPO4-based peptibody targeting LGR4/5/6 in preclinical models of colorectal cancer.

British journal of cancer·2025
Same author

Exploring the Potential of Epiregulin and Amphiregulin as Prognostic, Predictive, and Therapeutic Targets in Colorectal Cancer.

Onco·2025
Same author

Cetuximab increases LGR5 expression and augments LGR5-targeting antibody-drug conjugate efficacy in patient-derived colorectal cancer models.

bioRxiv : the preprint server for biology·2025
Same author

Antibody-Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Antitumor Activity in Colorectal Cancer.

Cancer research·2024

Area of Science:

  • Biochemistry
  • Analytical Chemistry
  • Materials Science

Background:

  • Estrogenic substances pose environmental and health risks.
  • Accurate detection of these compounds is crucial.
  • Existing detection methods may lack sensitivity or specificity.

Purpose of the Study:

  • To develop a highly sensitive and selective biosensor for estrogenic substances.
  • To utilize a genetically engineered estrogen receptor for enhanced detection capabilities.
  • To investigate the sensor's response to various estrogen receptor ligands.

Main Methods:

  • Development of a biosensor using a quartz crystal microbalance (QCM).
  • Immobilization of a genetically engineered alpha-estrogen receptor (αER) hormone-binding domain onto a piezoelectric quartz crystal.

Related Experiment Videos

  • Utilizing a single exposed cysteine for uniform receptor orientation.
  • Testing the sensor's response to known estrogen receptor ligands, agonists, antagonists, and non-binding substances.

    • Main Results:

    • The biosensor demonstrated a sensitive response to various estrogenic substances.
    • The sensor showed selectivity, with no response to non-binding substances like testosterone and progesterone.
    • Distinct responses were observed for agonists and antagonists, indicating differential binding detection.
    • Ligand binding induced changes in the structural rigidity of the immobilized receptor, leading to the sensor's response.

    Conclusions:

    • The developed QCM biosensor with immobilized, genetically engineered αER is effective for detecting estrogenic substances.
    • The biosensor offers high sensitivity and selectivity, distinguishing between binding and non-binding compounds.
    • The sensor's mechanism relies on ligand-induced changes in receptor structural rigidity, allowing differentiation of agonists and antagonists.